Detalles de la búsqueda
1.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585358
2.
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 467-476, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33136231
3.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682457
4.
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
BMC Cancer
; 20(1): 687, 2020 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703200
5.
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
Gastric Cancer
; 21(1): 84-95, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28497176
6.
Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer.
Int J Clin Oncol
; 23(1): 73-80, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28744724
7.
Electrical Conductivity through a Single Atomic Step Measured with the Proximity-Induced Superconducting Pair Correlation.
Phys Rev Lett
; 117(11): 116802, 2016 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27661710
8.
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 477-478, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300101
9.
UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.
Int J Clin Oncol
; 21(4): 696-703, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26710796
10.
Diarylrhodates as promising active catalysts for the arylation of vinyl ethers with Grignard reagents.
J Am Chem Soc
; 136(26): 9260-3, 2014 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24957673
11.
Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.
Cancer Sci
; 105(7): 812-7, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716542
12.
Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.
Invest New Drugs
; 32(2): 261-70, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23665950
13.
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
Gastric Cancer
; 16(2): 175-82, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22782463
14.
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.
Cancer Sci
; 103(8): 1502-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22537162
15.
Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Bioorg Med Chem Lett
; 22(16): 5174-6, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22818080
16.
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.
Gastric Cancer
; 15(3): 313-22, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22179434
17.
Criteria for non-surgical treatment of perforation during colorectal endoscopic submucosal dissection.
Digestion
; 85(2): 116-20, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22269291
18.
Opioid δ1 receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi.
Bioorg Med Chem Lett
; 21(16): 4710-2, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21764311
19.
Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.
Int J Clin Oncol
; 21(4): 704, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27380166
20.
Learning curve for endoscopic submucosal dissection of large colorectal tumors.
Dig Endosc
; 22(4): 302-6, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21175483